CHEMICAL DENERVATION FOR THE TREATMENT OF HYPERTONIA AND RELATED MOTOR DISORDERS - PHENOL AND BOTULINUM TOXIN

Authors
Citation
Mb. Glenn et E. Elovic, CHEMICAL DENERVATION FOR THE TREATMENT OF HYPERTONIA AND RELATED MOTOR DISORDERS - PHENOL AND BOTULINUM TOXIN, The journal of head trauma rehabilitation, 12(6), 1997, pp. 40-62
Citations number
95
ISSN journal
08859701
Volume
12
Issue
6
Year of publication
1997
Pages
40 - 62
Database
ISI
SICI code
0885-9701(1997)12:6<40:CDFTTO>2.0.ZU;2-Q
Abstract
Chemical neurolysis with phenol and neuromuscular blockade with botuli num toxin (Btx) are two commonly used approaches to chemical denervati on (CD) for the treatment of hypertonia and related motor disorders. P hysiologic and therapeutic effects, technique, safety and toxicology, and side effects and complications are discussed for each. The patient can be approached by first considering whether CD is indicated in the context of other available options. A kinesiologic and functional eva luation is used to determine the target goals according to impairment and disability. If CD is indicated, the clinician must decide whether neuromuscular blockade with Btx or chemical neurolysis with phenol is a better choice by considering the advantages and disadvantages of eac h for a given situation. If chemical neurolysis with phenol is indicat ed, then one must consider whether motor branch or mixed sensorimotor block is more worthwhile.